Consonance Capital Management LP Ovid Therapeutics Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$5.39 - $8.24 $13.9 Million - $21.2 Million
-2,570,878 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$2.67 - $7.91 $26,700 - $79,100
-10,000 Reduced 0.39%
2,570,878 $18.9 Million
Q1 2020

May 15, 2020
SELL
$2.03 - $4.35 $625,260 - $1.34 Million
-308,010 Reduced 10.66%
2,580,878 $7.69 Million
Q4 2019

Feb 14, 2020
BUY
$2.08 - $5.06 $6.01 Million - $14.6 Million
2,888,888 New
2,888,888 $12 Million

Others Institutions Holding OVID

# of Institutions
75
Shares Held
39M
Call Options Held
37.4K
Put Options Held
500
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $66.9M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email